Navigation Links
Healthcare VC Dr. Dinesh Patel to serve on Tute Genomics Board of Directors
Date:11/5/2013

SALT LAKE CITY, Nov. 5, 2013 /PRNewswire-iReach/ -- Dinesh Patel, PhD, co-founder of vSpring Capital (now Signal Peak Ventures), has joined the board of directors for Utah-based Tute Genomics, founded in 2012.  Tute is a professional grade, cloud-based application for the rapid and cost-effective analysis of entire human genomes for healthcare & biomedical research. Tute Genomics comes at a time when the current pace of interpretation of genomic data cannot keep up with the increasing volume of big data that is flooding hospitals & research institutions, calling for a system to analyze these data fast enough to infer the biological insights needed to stay ahead and guide decision-making.   This is the nature of Tute's business and is aligned well with Dr. Patel's knowledge base and skill set.

(Photo:  http://photos.prnewswire.com/prnh/20131105/MN10545)

Dr. Patel brings with him decades of experience which, combined with his belief in the mission of Tute Genomics, are sure to provide a great advantage to the growing company.  Dr. Patel has had leading roles at several life sciences companies. From 1985 to 1999, Dr. Patel served as Co-Founder, Chairman of the Board of Directors and President of TheraTech, Inc., a biotechnology company which he took public and eventually sold  for $350 million to Watson Pharmaceuticals. From 1999 to 2004 he was the Founder, Chairman, and President of Ashni Naturaceuticals, Inc., a company that specializes in the research, development and marketing of clinically tested and patent-protected nutraceutical products. Prior to Signal Peak Ventures, Dr. Patel was an active angel investor in over 20 biotech and technology companies.

Dr. Patel also served on the board of Mediconnect Global, a worldwide leader in medical record re
'/>"/>

SOURCE Tute Genomics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
2. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
3. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
4. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
5. Sequenom Announces Participation at the 23rd Annual Piper Jaffray Healthcare Conference
6. SuperNova Diagnostics® to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City
7. diaDexus, Inc. to Present at the Canaccord Genuity Healthcare Conference
8. ViroPharma to Participate in Two December Healthcare Investor Conferences
9. Celebrating 65 Years of Providing Superior Healthcare Products, Mission Pharmacal Continues to Thrive
10. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
11. Uroplasty to Present at the Oppenheimer 22nd Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2015)... 2015  MabVax Therapeutics Holdings, Inc. (OTCQB: MBVX) ("MabVax" ... company, announces the posting of the following Letter to ... Hansen to the Company,s website at www.mabvax.com ... have invested in MabVax Therapeutics because you share our ... difficult cancers.  You also share our excitement about our ...
(Date:8/5/2015)... , Aug. 5, 2015   Transparency Life ... company based on open innovation, today announced that ... innovative ulcerative colitis clinical trial designed to assess ... visits with data collected using a combination of ... visits with clinical trial staff and blood collections ...
(Date:8/5/2015)... ... August 05, 2015 , ... MTI-GlobalStem, a ... launch of an updated corporate identity, including new company name, logo and website. ... 2009. The company moved into a new, joint facility in 2014 to bring ...
(Date:8/4/2015)... ... August 04, 2015 , ... Graphite ... and process equipment, announces the appointment of Dennis Rawle as European Director of ... industries. Most recently, he was General Manager and Technical Sales Manager for pump ...
Breaking Biology Technology:MabVax Therapeutics Issues Letter to Stockholders 2MabVax Therapeutics Issues Letter to Stockholders 3MabVax Therapeutics Issues Letter to Stockholders 4MabVax Therapeutics Issues Letter to Stockholders 5MabVax Therapeutics Issues Letter to Stockholders 6MabVax Therapeutics Issues Letter to Stockholders 7MabVax Therapeutics Issues Letter to Stockholders 8MabVax Therapeutics Issues Letter to Stockholders 9MabVax Therapeutics Issues Letter to Stockholders 10MabVax Therapeutics Issues Letter to Stockholders 11MabVax Therapeutics Issues Letter to Stockholders 12MabVax Therapeutics Issues Letter to Stockholders 13Transparency Life Sciences Announces Start Of Ulcerative Colitis Clinical Trial Assessing Feasibility Of Decentralized Patient Data Collection 2Transparency Life Sciences Announces Start Of Ulcerative Colitis Clinical Trial Assessing Feasibility Of Decentralized Patient Data Collection 3Transparency Life Sciences Announces Start Of Ulcerative Colitis Clinical Trial Assessing Feasibility Of Decentralized Patient Data Collection 4MTI-GlobalStem Announces Updated Company Identity and Website 2MTI-GlobalStem Announces Updated Company Identity and Website 3Dennis Rawle Joins Graphite Metallizing Corporation 2
(Date:7/23/2015)... Aware, Inc. (NASDAQ: AWRE ), a leading ... for its second quarter ended June 30, 2015.  ... million, a decrease of 33% compared to $6.8 million in ... quarter of 2015 was $0.3 million, or $0.01 per diluted ... share, in the same period a year ago.  ...
(Date:7/21/2015)... 21, 2015 Passwords have proven futile ... the recent U.S. Office of Personnel Management breach. ... infosec conundrum, but developers and end-users are concerned ... this dilemma, Biometrics-as-a-Service provider HYPR Corp. announced today ... for third party integration. A ...
(Date:7/9/2015)... SAN JOSE, Calif. , July 9, 2015 /PRNewswire/ ... human interface solutions, announced today that it will report ... 2015 on Thursday, July 30, 2015 after the close ... call for analysts and investors at 2:00 p.m. PT ... information.    To participate on the live ...
Breaking Biology News(10 mins):Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2
... French . , Quebec City, August 25, 2011A diet rich ... according to a study conducted by Universit Laval researchers. The team, ... extent of brain damage following a stroke was reduced by 25% ... study can be found on the website of the journal ...
... DURHAM, N.C. Aerobic exercise is your best bet when ... study finds. When Duke University Medical Center researchers conducted ... combination of the two, they found aerobic exercise to be ... belly fat that,s most damaging to your health. This ...
... have developed the first practical method to create a compound ... naturally in a species of moss found in China, is ... disease in China since the late 1990s and is sold ... memory. Scientists believe it could also potentially combat the effects ...
Cached Biology News:Omega-3s reduce stroke severity 2Aerobic exercise bests resistance training at burning belly fat 2Scientists create natural Alzheimer's-fighting compound in lab 2
G-protein coupled purinergic receptor P2Y8...
Acid phosphatase (Potato). Monospecific by IEP. Some cross reactivity between Acid phosphatases of other species may occur....
Rat monoclonal [HK5.3] to B7 RP1 (Biotin) ( Abpromise for all tested applications). entrezGeneID: 23308 SwissProtID: O75144...
... to Yersinia pestis This antibody ... . Immunogen: Purified ... vaccine strain EV76. ... F1 capsular antigen. There is no ...
Biology Products: